ArTara Therapeutics Q2 EPS $(1.14) Up From $(1.22) YoY

ArTara Therapeutics (NASDAQ:TARA) reported quarterly losses of $(1.14) per share. This is a 6.56 percent increase over losses of $(1.22) per share from the same period last year.

ArTara Therapeutics (NASDAQ:TARA) reported quarterly losses of $(1.14) per share. This is a 6.56 percent increase over losses of $(1.22) per share from the same period last year.

Total
0
Shares
Related Posts